Who Paid My Doc
Tri-Luma
Drug Melasma
NDC 0299-5950-30
General payments
$21,307
Research payments
$0
Through program year 2022, $21,307 in general payments and $0 in research payments were reported against Tri-Luma (Melasma).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $6,976 | 304 |
| 2021 | General | $382 | 10 |
| 2020 | General | $895 | 4 |
| 2019 | General | $13,054 | 828 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
1,146 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.